Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 11/2003

01-11-2003 | Original Articles

A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old

Authors: Dr. Carmen L. Lewis, MD, MPH, Michael P. Pignone, MD, MPH, Stacey L. Sheridan, MD, MPH, Stephen M. Downs, MD, MS, Linda S. Kinsinger, MD, MPH

Published in: Journal of General Internal Medicine | Issue 11/2003

Login to get access
Metadata
Title
A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old
Authors
Dr. Carmen L. Lewis, MD, MPH
Michael P. Pignone, MD, MPH
Stacey L. Sheridan, MD, MPH
Stephen M. Downs, MD, MS
Linda S. Kinsinger, MD, MPH
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 11/2003
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1046/j.1525-1497.2003.21152.x

Other articles of this Issue 11/2003

Journal of General Internal Medicine 11/2003 Go to the issue

Editorials

Why does framing influence judgment?

Original Articles

African American church participation and health care practices

Reviews

Describing treatment effects to patients

Editorials

Health care and faith communities

Original Articles

Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France

Brief Reports

Incidence of venous thromboembolic events among nursing home residents
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits